Anticoagulation

AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s
AHA 25: The OCEAN Trial

Atul Verma

Watch time: 3m 46s
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC

Josep Rodés-Cabau

Watch time: 7m 4s
ESC 25: 4 Heart Failure Trials That Will Change My Practice

Michelle Kittleson

Watch time: 9m 41s
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Davide Capodanno, Sneha Shah Jain

Watch time: 19m 30s (6 videos)
ESC 25: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 11m 8s
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain

Watch time: 31m 49s
Hot Line Sessions Revealed for ESC Congress 2025

ESC Congress 2025 Scientific Programme

SCAI 25: Insights from the TRITAVI Registry

Francesco Pelliccia

Watch time: 11m 23s
ACC 25: Optimizing DAPT Duration

Hyo-Soo Kim

Watch time: 9m 39s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)
EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 5m 20s

Yugo Yamashita

Harriette Van Spall, Stefan James

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

Nazli Okumus, Ashley Park, Eugene Yuridistky, et al

Read time: 29m 12s

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s

Sonika Malik, Anju Bhardwaj, Matthew Eisen, et al

Hot Line Sessions Revealed for ESC Congress 2025

ESC Congress 2025 Scientific Programme

Payam Pournazari, Su Min Chang, Stephen H Little, et al

ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s

Media

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng , et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan

Watch time: 17m 13s

Broadcast

Anticoagulation

Vascular Disease and Surgery
Radcliffe Premiere TV: ESC 2022

Watch time: 3h 52m 31s
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 6s

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

Media

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain

Watch time: 31m 49s

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng , et al

Watch time: 59m 32s

Broadcast

Anticoagulation
Extended Thromboprophylaxis in Medically Ill Patients

Alex Spyropoulos, Gary E Raskob,

Watch time: 1h 2m 6s

Davide Capodanno, Sneha Shah Jain

Watch time: 19m 30s (6 videos)
AHA 25: The OCEAN Trial

Atul Verma

Watch time: 3m 46s
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC

Josep Rodés-Cabau

Watch time: 7m 4s
ESC 25: The HI-PRO Trial

Gregory Piazza

Watch time: 5m 10s
ESC 25: 4 Heart Failure Trials That Will Change My Practice

Michelle Kittleson

Watch time: 9m 41s
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF

Carolyn Lam, Jeffrey Weitz

Watch time: 10m 29s
ESC 25: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 11m 8s
CRT 2020: Duration of DAPT treatment in ST prevention

Dean J Kereiakes

Watch time: 11m 55s

Articles

Type and Duration of Antithrombotic Treatment in Complex PCI

Despoina-Rafailia Benetou

,

Charalampos Varlamos

,

Christos Pappas

,

Fotios Kolokathis

,

Dimitrios Alexopoulos

,

Published:

13 October 2021

Citation:

US Cardiology Review 2021;15:e17.

DOI:

https://doi.org/10.15420/usc.2020.30
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 375
  • Downloads: Downloads 101
  • Read time: 18m

Antithrombotic Therapy in Complex PCI Patients Under OAC

Despoina-Rafailia Benetou

,

Panayotis K Vlachakis

,

Charalampos Varlamos

,

Dimitrios Alexopoulos

,

Published:

20 May 2021

Citation:

US Cardiology Review 2021;15:e09.

DOI:

https://doi.org/10.15420/usc.2020.31
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 346
  • Downloads: Downloads 192

Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin

Johny Nicolas

,

Usman Baber

,

Roxana Mehran

,

Published:

15 May 2020

Citation:

US Cardiology Review 2020;14:e04.

DOI:

https://doi.org/10.15420/usc.2019.02
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1257
  • Downloads: Downloads 69
  • Citations: 2

Antithrombotics in TAVR

Mathew R Williams

,

Kelsey Grossman

,

Homam Ibrahim

,

Published:

07 February 2020

Citation:

US Cardiology Review 2019;13(2):88–93.

DOI:

https://doi.org/10.15420/usc.2019.01
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 297
  • Downloads: Downloads 20